Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
[1] Important: Tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Market Demand and Competition: With the recent surge in demand for these drugs for both diabetes and obesity, companies can command higher prices
Jan 2019;68(1):220-225
Switching Injection Sites to Reduce GLP-1 Nausea Though there is no scientific evidence supporting the idea that changing the injection site reduces nausea, some patients have reported a possible reduction in nausea by rotating their injection sites
US$ 23.27
US$ 21.48
US$ 26.31
US$ 20.36
